Page last updated: 2024-10-28

gyki 52466 and Epilepsy, Tonic-Clonic

gyki 52466 has been researched along with Epilepsy, Tonic-Clonic in 2 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Epilepsy, Tonic-Clonic: A generalized seizure disorder characterized by recurrent major motor seizures. The initial brief tonic phase is marked by trunk flexion followed by diffuse extension of the trunk and extremities. The clonic phase features rhythmic flexor contractions of the trunk and limbs, pupillary dilation, elevations of blood pressure and pulse, urinary incontinence, and tongue biting. This is followed by a profound state of depressed consciousness (post-ictal state) which gradually improves over minutes to hours. The disorder may be cryptogenic, familial, or symptomatic (caused by an identified disease process). (From Adams et al., Principles of Neurology, 6th ed, p329)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kubová, H1
Világi, I1
Mikulecká, A1
Mares, P1
Smith, SE1
Dürmüller, N1
Meldrum, BS1

Other Studies

2 other studies available for gyki 52466 and Epilepsy, Tonic-Clonic

ArticleYear
Non-NMDA receptor antagonist GYKI 52466 suppresses cortical afterdischarges in immature rats.
    European journal of pharmacology, 1997, Aug-20, Volume: 333, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Cerebral Cortex; Electric Stimulation; Electrodes, Im

1997
The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy.
    European journal of pharmacology, 1991, Aug-29, Volume: 201, Issue:2-3

    Topics: Acoustic Stimulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Benzodiazepin

1991